Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
JAMA Cardiology
|
February 6, 2020
Cardiovascular Functional Reserve Before and After Kidney Transplant
Kenneth Lim, Stephen M S Ting, Thomas Hamborg, et al.
Journal of the American Heart Association
|
July 21, 2022
Initiation of Dialysis Is Associated With Impaired Cardiovascular Functional Capacity
Eliott Arroyo, Peter E Umukoro, Heather N Burney, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
October 14, 2024
Impairment of Cardiovascular Functional Capacity in Mild-to-Moderate Kidney Dysfunction
Kenneth Lim, Matthew Nayor, Eliott Arroyo, et al.
Journal of the American Heart Association
|
February 18, 2022
Myocardial Cytoskeletal Adaptations in Advanced Kidney Disease
Arvin Halim, Gayatri Narayanan, Takashi Hato, et al.
Annals of the Rheumatic Diseases
|
January 7, 2019
Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial
Rachel B Jones, Thomas F Hiemstra, Jose Ballarin, et al.
BMC Medical Ethics
|
January 23, 2020
Legal and ethical framework for global health information and biospecimen exchange - an international perspective
Lara Bernasconi, Selçuk Şen, Luca Angerame, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
August 31, 2021
Effects of Spironolactone and Chlorthalidone on Cardiovascular Structure and Function in Chronic Kidney Disease: A Randomized, Open-Label Trial
Nicola C Edwards, Anna M Price, Samir Mehta, et al.
BMC Infectious Diseases
|
February 11, 2025
Prophylaxis for renal patients at risk of COVID-19 infection: results from the intranasal niclosamide randomised, double blinded, placebo controlled arm of the PROTECT-V platform trial
Toby J L Humphrey, Wendi Qian, Michael Chen-Xu, et al.
American Heart Journal
|
September 11, 2017
A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial
Manvir K Hayer, Nicola C Edwards, Gemma Slinn, et al.
Nature Medicine
|
April 27, 2026
Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trial
Ravi Thadhani, Thomas F Hiemstra, Manu Vatish, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
JAMA Cardiology
|
February 6, 2020
Cardiovascular Functional Reserve Before and After Kidney Transplant
Kenneth Lim, Stephen M S Ting, Thomas Hamborg, et al.
Journal of the American Heart Association
|
July 21, 2022
Initiation of Dialysis Is Associated With Impaired Cardiovascular Functional Capacity
Eliott Arroyo, Peter E Umukoro, Heather N Burney, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
October 14, 2024
Impairment of Cardiovascular Functional Capacity in Mild-to-Moderate Kidney Dysfunction
Kenneth Lim, Matthew Nayor, Eliott Arroyo, et al.
Journal of the American Heart Association
|
February 18, 2022
Myocardial Cytoskeletal Adaptations in Advanced Kidney Disease
Arvin Halim, Gayatri Narayanan, Takashi Hato, et al.
Annals of the Rheumatic Diseases
|
January 7, 2019
Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial
Rachel B Jones, Thomas F Hiemstra, Jose Ballarin, et al.
BMC Medical Ethics
|
January 23, 2020
Legal and ethical framework for global health information and biospecimen exchange - an international perspective
Lara Bernasconi, Selçuk Şen, Luca Angerame, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
August 31, 2021
Effects of Spironolactone and Chlorthalidone on Cardiovascular Structure and Function in Chronic Kidney Disease: A Randomized, Open-Label Trial
Nicola C Edwards, Anna M Price, Samir Mehta, et al.
BMC Infectious Diseases
|
February 11, 2025
Prophylaxis for renal patients at risk of COVID-19 infection: results from the intranasal niclosamide randomised, double blinded, placebo controlled arm of the PROTECT-V platform trial
Toby J L Humphrey, Wendi Qian, Michael Chen-Xu, et al.
American Heart Journal
|
September 11, 2017
A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial
Manvir K Hayer, Nicola C Edwards, Gemma Slinn, et al.
Nature Medicine
|
April 27, 2026
Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trial
Ravi Thadhani, Thomas F Hiemstra, Manu Vatish, et al.
Page
of 5